Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt
1999
Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
2000
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. Wilson
1999
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding
1998
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Acute kidney injury
2012 Standout
Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome
2010
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops
2003
Liver fibrosis
2005 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
2016
Prophylactic Use of Transjugular Intrahepatic Portosystemic Shunt Aids in the Treatment of Refractory Ascites
2013
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
"Salvage" Transjugular Intrahepatic Portosystemic Shunts: Gastric Fundal Compared With Esophageal Variceal Bleeding
1998
Antithrombotic Therapy for VTE Disease
2016 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Intensive Care Unit Management of Patients with Liver Failure
2014
Treatment of Hepatic Encephalopathy
1997
Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism
2003
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
The biology of VEGF and its receptors
2003 Standout
TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis
2014
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
2006
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
1996
Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
2004
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
1998
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation
2010
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data
2007
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: Results in 85 patients
1996
VEGF receptor signalling ? in control of vascular function
2006 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
2004 StandoutNobel
Acute kidney injury
2019 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club
2003
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
2011
Clinical Significance of Pleural Effusion in Acute Aortic Dissection
2002
A CONTROLLED ANALYSIS OF THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN LIVER TRANSPLANT RECIPIENTS
1997
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
2000
Management of Cirrhosis and Ascites
2004
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Liver transplantation in patients with hepatic hydrothorax
2005
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
2006
Angiogenesis in life, disease and medicine
2005 StandoutNature
A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites
2005
Outcomes of patients with chest tube insertion for hepatic hydrothorax
2009
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Pulmonary complications in chronic liver disease
2013
The North American Study for the Treatment of Refractory Ascites
2003
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
2013
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
2010 StandoutNobel
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Male orangutan subadulthood: A new twist on the relationship between chronic stress and developmental arrest
2002
Regulation of Vascularization by Hypoxia‐Inducible Factor 1
2009 StandoutNobel
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
2007
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without ascites
1998
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial
1996
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis
2015
Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases
1997
Improved Quality of Life in Patients with Refractory or Recidivant Ascites after Insertion of Transjugular Intrahepatic Portosystemic Shunts
2002
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
1998
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Modes of resistance to anti-angiogenic therapy
2008 Standout
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
2002
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer
2002
Advances in Malignant Mesothelioma
2005 Standout
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis
2016
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study
2000
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
2000
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
2014
Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
1999
Novel Mammalian Herpesviruses and Lineages within the Gammaherpesvirinae : Cospeciation and Interspecies Transfer
2008
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
2001
Wound Healing: A Cellular Perspective
2018 Standout
Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis
2005
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
The Influence of Social Hierarchy on Primate Health
2005 StandoutScience
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems
2008 StandoutNobel
Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
2000
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
2003
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Andreas Ochs being referenced
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients
2001
Severe veno‐occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation – role of transjugular intrahepatic portosystemic shunt (TIPS)
2001
The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites
1995
Platelet Aggregation and Platelet–Derived Growth Factor Inhibition for Prevention of Insufficiency of the Transjugular Intrahepatic Portosystemic Shunt: A Randomized Study Comparing Trapidil Plus Ticlopidine With Heparin Treatment
1999
How much reduction in portal pressure is necessary to prevent variceal rebleeding? a longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts
2001
Transjugular Intrahepatic Portosystemic Shunt
2005
The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding
1994
Novel Simian Homologues of Epstein-Barr Virus
2003
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
1999
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
1999
The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art
1998
Fecal progestagen evaluations to monitor the estrous cycle and pregnancy in the okapi (Okapia johnstoni)
1993